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Abstract
Background: Supplementing pregnant and lactating mothers with small quantity lipid-based nutrient supplements
(SQ-LNS) has resulted in improvements in birth outcomes in some low-income settings. In order to be effective,
SQ-LNS must be consumed regularly over sustained periods.
Methods: The objective was to assess and compare acceptability of and adherence to SQ-LNS consumption
among pregnant and lactating women in Ghana and Malawi throughout 12 months of supplementation. We
enrolled women before 20 gestation weeks into randomized trials in Ghana (n = 1320) and Malawi (n = 869). In the
SQ-LNS group participants received a 20 g sachet of supplement per day during pregnancy and the first 6 months
of lactation. In the control groups participants received multiple micronutrients (MMN) during pregnancy and
lactation or iron and folic acid (IFA) during pregnancy and calcium during lactation. We used questionnaires to
collect data on self-reported adherence to daily use of supplements and conducted in-depth interviews with
women in the SQ-LNS group to examine acceptability.
Results: The mean self-reported adherence during the supplementation period was lower in Ghana (79.9 %) than
in Malawi (91.7 %) for all supplements (difference 11.8 %, P < 0.001). Over time, adherence increased in Malawi but
decreased in Ghana. In both countries, adherence in the SQ-LNS group was non-inferior to that in the control
groups. Participants typically reported consuming SQ-LNS as instructed but when interviewers queried about
experiences, most of the women described incidents of non-adherence. A usual reason for not consuming SQ-LNS
was nausea and vomiting during pregnancy. Especially in Malawi, women reported sharing SQ-LNS with families
and friends. Sustained use of SQ-LNS was attributed to expected health benefits and favorable sensory attributes.
Often women compared their pregnancy to previous ones, and were of the view that SQ-LNS made a positive
difference.
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Conclusion: Self-reported sustained adherence to consume SQ-LNS daily was high in both sites but lower in
Ghana than in Malawi. In Ghana, adherence decreased over time whereas in Malawi adherence increased.
Acceptability and adherence appeared interlinked, complex and context-related. Sustained consumption of SQ-LNS
may require tailoring interventions by context.
Trial registration: The Ghana trial was registered at clinicaltrials.gov as NCT00970866, and the Malawi trial as
NCT01239693.
Keywords: Small-quantity lipid-based nutrient supplements, Adherence, Acceptability, Women, Pregnancy,
Lactation, Ghana, Malawi
Abbreviations: IFA, Iron and folic acid tablets; MMN, Multiple micronutrient tablets; SD, Standard deviation; SQ-
LNS, Small quantity lipid-based nutrient supplement
Background
Linear growth failure in childhood, stunting, is the most
common growth deficit globally. Stunting prevalence has
been decreasing slowly and 165 million children were
estimated to be stunted in 2011 [10]. Typically, stunting
begins in utero and continues especially during the
vulnerable period of complementary feeding [25, 27].
Among other things, inadequate maternal diet during
pregnancy and lactation, combined with increased
nutrient requirements, play a crucial role in the etiology
of stunting [1]. In the 2030 Agenda for Sustainable
Development, reduction of stunting is used as an indica-
tor for the achievement of the nutrition target (http://
www.un.org/sustainabledevelopment/hunger). As more
global attention is directed towards length gain in in-
fancy and childhood, there is a need to better under-
stand the potential of interventions towards reaching the
global goal.
Small-quantity lipid-based nutrient supplements (SQ-
LNS) are designed to be used as one component in
nutrition interventions for pregnant and lactating
women and children from 6 months onwards to prevent
moderate malnutrition leading to stunting. SQ-LNS are
a family of energy-dense pastes that contain protein,
carbohydrates, and micronutrients embedded in a lipid
base, to be mixed with regular foods [7]. There have
been several trials on supplementing children with SQ-
LNS [2, 8, 9, 21, 26]. Supplementing pregnant and
lactating mothers with SQ-LNS has resulted in improve-
ments in birth outcomes in some low-income settings
[4, 8, 9, 24]. Both maternal and child supplementation
have produced mixed efficacy results with respect to child
growth; supplementing women with SQ-LNS during
pregnancy and the first 6 months of lactation and their
children between 6 and 18 months of age did not impact
child length at 18 months in Malawi [9], but had a positive
impact on child length at 18 months in Ghana [5].
Differences in the study contexts and participant
adherence to the intervention may possibly explain this
heterogeneity [22].
Among others factors, the efficacy results of a comple-
mentary feeding intervention depend on sustained con-
sumption of the products, i.e. adherence. In the present
report we analyze longitudinal adherence among partici-
pants who were receiving SQ-LNS during pregnancy
and the first six months of lactation as part of two ran-
domized trials in Ghana and in Malawi. The objectives
of the present study were twofold. Firstly, using quanti-
tative data, we examined self-reported adherence to con-
sume SQ-LNS and the control products (multiple
micronutrients tablets, MMN and iron and folic acid
tablet, IFA) daily. We compared mean adherence be-
tween the two countries and between SQ-LNS and con-
trol groups. Secondly, using qualitative data, we assessed
participants’ experiences and acceptability of SQ-LNS.
Methods
Trial context
We collected the data as part of iLiNS-DYAD trials in
Ghana and in Malawi and the main results have been
published earlier [4, 8, 9]. In brief, the main aim was to
test a hypothesis that provision of 20 g sachet SQ-LNS
to mothers during pregnancy and during the first
6 months of lactation and to their infants from 6 to
18 months of age would result in favorable birth out-
comes (birth length and weight) and improved child
growth compared to children of mothers in the two con-
trol groups: one receiving either multiple micronutrient
tablets (MMN) during pregnancy and lactation or iron
and folic acid tablets during pregnancy (IFA) and pla-
cebo tablets during lactation. The SQ-LNS were formu-
lated to provide 1x or 2x the recommended dietary
allowance (RDA) of the chosen nutrients both for the
mothers and the children [7]. We have already published
trial settings and the growth results: In Ghana there was
an increase in birth size of infants of primiparous
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women who received SQ-LNS and the growth effect was
sustained till 18 months (iLiNS project, [5]). In Malawi
there was no effect on growth at birth or at 18 months
[8, 9].
This paper reports on acceptability of SQ-LNS and on
adherence to recommended consumption, relative to in-
structions given by research nurses to each woman at
enrolment: 1) she should take the supplement every day
while in study until 6 months during lactation, 2) she
should take the supplement without sharing it, 3) she
should mix SQ-LNS with a small amount of food before
eating the rest of the meal. This was to ensure that the
entire content of each SQ-LNS sachet was consumed.
Study areas and participants
In Ghana, the trial was conducted at the Somanya-
Kpong area, about 70 km north of Accra (national cap-
ital). Participants were enrolled from the four main
health facilities in the area. The study area consisted of
several adjoining, semi-urban communities stretching
about 20 km. The area was served by electricity and
potable water from the public supply. Most inhabitants
were subsistence farmers or petty traders and were
neither poor nor rich by Ghanaian standards. The staple
diet consisted of maize, cassava, rice, fish, and leafy vege-
tables [4].
In Malawi, the trial was conducted in Mangochi
District situated at the southern end of Lake Malawi.
Participants were enrolled at antenatal clinics in a
government-run hospital and health centers and in a
private hospital. The catchment area was predominantly
rural with no electricity supply and water drawn from
wells and boreholes. Most inhabitants subsisted on
farming maize and fishing. The staple diet consists of
stiff maize porridge consumed with sauce made of vege-
tables and some fish or meat. Households often suffered
from lack of food and seasonal hunger before the new
harvest [8, 9].
The target population comprised pregnant women
who came for antenatal care at any of the study hospitals
or clinics. The study teams screened and enrolled partic-
ipants who met the inclusion criteria: ultrasound scan-
confirmed pregnancy of no more than 20 completed ges-
tation weeks, having antenatal cards with complete med-
ical and examination history (Ghana), residence in the
defined catchment area, availability during the period of
the study, and signed or thumb-printed informed con-
sent. Exclusion criteria were: age less than 15 years for
Malawi and less than 18 y for Ghana, antenatal cards in-
dicating HIV infection status (Ghana), need for frequent
medical attention due to a chronic health condition,
diagnosed asthma treated with regular medication,
severe illness warranting hospital referral, history of
peanut allergy, history of anaphylaxis or serious allergic
reaction to any substance requiring emergency medical
care, pregnancy complications evident at enrolment visit,
earlier participation in the iLiNS-DYAD trial (during a
previous pregnancy), or concurrent participation in any
other clinical trial.
Data collection
We used mixed methods to collect data in order to pro-
vide a comprehensive analysis of adherence to and ac-
ceptability of SQ-LNS [11]. For quantitative analysis the
sample size was determined by the main studies [4, 9].
In Malawi, research assistants visited the homes of the
participants weekly. They delivered a two-wk ration of
SQ-LNS, IFA or MMN at every other visit. Every week,
they administered a questionnaire about adherence to
recommended daily consumption of the supplement
during the previous week. In Ghana, home visit teams
went to the women biweekly to deliver a two-week sup-
ply of supplements and documented adherence to the
recommended daily consumption of the supplements
using a questionnaire-based interview.
For qualitative analysis, female researchers who had
not previously interacted with the study participants
made two home visits to a subset of mothers who re-
ceived SQ-LNS and conducted in-depth interviews
about their experiences with the supplements using a
thematic interview guide. The first interview was done
soon after enrolment in early pregnancy and the second
interview between 6 and 12 months postpartum. We
conducted about 30 interviews which allowed us to
select the interviewees purposively to include mothers of
different ages, educational levels, parity and living
situations. In Ghana, where different languages were
spoken in the study area (Twi, Ewe, Ga, Krobo), the
researcher used a thematic interview guide in English
but conducted the interviews using vernacular. These
female researchers were trained to pose the interview
questions in a consistent manner. In Malawi, we
translated the thematic guides into the local languages
(Chichewa, Chiyao). In both settings, an interpreter flu-
ent in the local language was present if the researcher
was not fluent in the language used for the interview.
Data analysis
Figure 1 presents a concept map for data analysis which
we created based on previous literature and preliminary
examination of data. Our assumption was that the effect-
iveness of the intervention depends on how meticulously
women followed the instructions to consume the supple-
ments daily; in other words, adherence. A necessary in-
terconnected concept is acceptability which has been
conceptualized as a favorable attitude towards a product,
predisposing a person to be willing to use it according to
instructions [29].
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For the present analysis, we considered adherence as
an etic (outsider) perspective constructed by the trial de-
signers. For capturing this perspective, we analyzed the
aspects of data covering the instructions the team gave
and whether products were reported to be used as
intended. We considered acceptability as an emic
(insider) perspective and we analyzed the segments of
transcripts where women narrated how they had used
SQ-LNS and justification for their behavior.
In Malawi, data clerks entered questionnaire-based
weekly data into a tailor-made database through scan-
ning, digital character recognition, and manual verifica-
tion of critical variables and suspicious entries. In
Ghana, data clerks double-entered questionnaire-based
biweekly data into a computer database manually, with
regular quality control checks by the data quality control
officer. We analysed these data for biweekly and mean
adherence percentages based on self-reported intake of
the products (i.e. days consumed) from enrolment till
25 weeks during lactation or end of participation, which-
ever came first. We based the analysis on the principle
of modified intention-to-treat, i.e. we included all
randomized participants into the analysis if they had 4
or more visits during pregnancy and 4 or more visits
during lactation.
Our preliminary analysis of in-depth interviews
suggested lower adherence in Ghana than in Malawi.
For testing a hypothesis of adherence being lower among
Ghanaian than among Malawian women, for all
supplement types, we performed a Mann–Whitney U
test using the overall adherence percentage. To test if
adherence was lower for SQ-LNS (a novel supplement)
than for IFA and MMN (controls), we predefined a 10 %
non-inferiority margin sufficient for practical relevance.
For testing the hypothesis of an increase in adherence
percentage over time, we calculated the rate of change
in the biweekly adherence percentage within each study
group. We created a regression model and calculated a
slope for adherence percentage over time for each par-
ticipant. For comparing adherence between pregnancy
and lactation within countries we performed a Wilcoxon
signed-rank test. For all the quantitative analysis, we
used data collected from 20 weeks gestation to 25 weeks
after delivery. However, visits occurring after 40 weeks
gestation were excluded, since there were very few.
Additionally, we excluded the first wk after delivery
when calculating adherence during lactation, because
data collected 1 week post-partum may have included a
wk of pregnancy and a wk of lactation.
Researchers recorded the in-depth interviews and
transcribed them verbatim into the language used during
the interview, and then translated into English. For
organising and analysing the data, we used a modified
framework method, which belongs to the family of
content analysis and is geared towards policy and
practice-oriented findings [17]. According to this method,
we first familiarized ourselves with the interviews; based
on that, we agreed on the codes to be used in an initial
Fig. 1 Concept map of adherence and acceptability
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analytical framework and formed a matrix which was used
for interpreting the data [14, 17]. A distinctive aspect of
framework analysis is that it allows themes to develop
both from the research questions and from the narratives
of research participants [28]. Themes were developed in
relation to participants’ experiences with the use of SQ-
LNS, including adherence accounts, sensory attributes
and side effects, food preferences and convenience, needs
perception and benefits, and the social environment. In
order to guard against researcher bias and help ensure
that the data accurately reflected the perception of the in-
terviewees, two researchers (MKK, UA) generated codes
and themes independently. The coded segments of the
transcripts were shared and compared for discrepancies.
In very rare instances when there was disagreement, both
researchers discussed the codes and themes and arrived at
a consensus. The two researchers then produced a the-
matic framework together; the framework was revised
throughout the coding process to ensure it was appropri-
ate for the data, and then applied systematically to both
coded and yet-to-be coded transcripts. Additionally, we
used focused coding, concentrating on interview segments
that were about women’s experiences with consuming
SQ-LNS [13]. Using this approach, we summarized data
into thematic matrices for identifying social, cultural and
behavioral explanations for consuming or not consuming
SQ-LNS on a daily basis. We used Atlas.ti software, ver-
sion 7 for coding.
Results
Success of follow-up
We collected data in Ghana from December 2009 through
August 2012 and in Malawi from February 2011 to August
2012. In Ghana, 1320 and in Malawi 869 pregnant women
were enrolled into the study. Background characteristics of
the participants at enrollment are presented in Table 1. Par-
ticipant flow and reasons for loss to follow-up are presented
in Additional file 1: Figure S1. In Ghana, 127 (9.6 %) and in
Malawi 150 (17.3 %) women were lost to follow-up during
pregnancy and the first 6 months during lactation.
We had transcripts of interviews with 32 women in
Ghana and 30 women in Malawi during early pregnancy.
During lactation we re-interviewed 30 women in Ghana
and 27 women in Malawi. In Malawi, three of the infants
died before the second interview, with one being a still-
birth. In Ghana, one infant died and one mother ended
participation in the study. We did not attempt to inter-
view these women.
Self-reported adherence to consume supplement daily
The mean (SD) self-reported overall adherence to sup-
plement consumption was 79.9 % (16.9 %) in Ghana and
91.7 % (6.8 %) in Malawi (Mann–Whitney U test for
equality of percentages: z = −20.48, P < 0.001). In both
countries, some participants reported close to full adher-
ence but some reported that they consumed the supple-
ments very seldom (Fig. 2). The mean overall adherence
was 9–16 %-points lower in Ghana than in Malawi for
each supplement type, both during pregnancy and lacta-
tion (P < 0.001), Table 2.
Comparison between the supplemented groups indi-
cated non-inferiority of the adherence in the SQ-LNS
group as compared to the IFA and MMN groups in
Malawi and Ghana (lower bound of 95 % CI above 90 %
of mean of IFA and MMN) (Fig. 3).
The mean overall adherence increased over time in
Malawi in all supplemented groups (P < 0.001 for each
slope, one-sample t-test for rate of change) whereas
in Ghana, the mean overall adherence decreased over
time in all supplemented groups (P < 0.001 for each
slope, one-sample t-test for rate of change) (Fig. 4).
In Ghana mean (SD) adherence was 81.5 % (17.6 %) in
pregnancy and 78.5 % (20.8 %) during lactation (P < 0.001,
Wilcoxon signed-rank test). In Malawi mean (SD) adher-
ence was 90.1 % (8.9 %) in pregnancy and 93.4 % (8.6 %)
during lactation (P < 0.001, Wilcoxon signed-rank test).
Adherence accounts in in-depth interviews
In-depth interviews offered some insight into the re-
ported weekly adherence to SQ-LNS (referred to as
Table 1 Participant and household characteristics at enrolment, by intervention group
Characteristic Ghana Malawi
SQ-LNS MMN IFA P-value* SQ-LNS MMN IFA P-value*
Number of participants 440 439 441 288 291 290
Age y, mean (SD) 26.9 (5.6) 26.9 (5.4) 26.4 (5.6) 0.24 25.1 (6.3) 24.5 (5.8) 25.0 (6.0) 0.50
Schooling y, mean (SD) 7.6 (3.9) 7.6 (3.6) 7.8 (3.5) 0.60 4.0 (3.7) 4.0 (3.4) 3.8 (3.5) 0.79
Proportion of married 92.1 % 93.6 % 92.5 % 0.65 85.6 % 85.6 % 84.8 % 0.95
Proportion of primiparous women 33.4 % 32.6 % 35.4 % 0.67 24.0 % 23.4 % 23.2 % 0.97
Household asset index, mean (SD)a −0.09 (1.00) 0.06 (0.97) 0.04 (1.02) 0.05 0.15 (1.94) 0.00 (1.78) −0.03 (1.85) 0.47
Head of household is respondent’s husband 67.0 % 64.7 % 65.0 % 0.72 45.5 % 43.6 % 44.1 % 0.91
*Chi-squared test or ANOVA/Kruskal-Wallis
aStandardized within each site to a mean of 0 and SD of 1. Comparison across sites is not meaningful
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Nkatepa in Ghana and as Chiponde Chatsopano in
Malawi). Almost all women memorized the instructions
correctly and initially reported that they had consumed
SQ-LNS as instructed. Additionally, they emphasized
that the instructions were given by a nurse (some Mala-
wians said doctor) at a health facility and therefore they
should be closely obeyed. However, in the course of the
interviews, when the interviewer queried about experi-
ences with SQ-LNS using probes, most of the women
described incidents of non-adherence. Along the same
lines, most of the initial reactions to questions about ex-
periences with SQ-LNS were positive but during the in-
terviews some women also brought forward some
negative experiences. Components of acceptability and
adherence were different among individuals and also in
Ghana as compared to Malawi, and when appropriate
the text below reflects this variation.
Sensory attributes and side effects
In both countries, sensory attributes (taste, smell, palat-
ability, texture, color) were central in interview accounts.
In general in Ghana, participants were more critical, dis-
cussed organoleptic properties in more detail than in
Malawi and expressed various sentiments about the
properties and qualities of Nkatepa. According to several
of the interviewed Ghanaian women, they noticed the
smell (scent) or taste of groundnut and did not like it.
Others indicated that they felt on their tongues or tasted
or smelled the “medicines” that were added to the Nka-
tepa. Some women described it as being too sweet,
others described it as being bitter or having a bitter
aftertaste; a few others described it as neither sweet nor
bitter but tasteless. For some women, the taste or tex-
ture of Nkatepa either prevented them from enjoying it
or made it difficult for them to consume it as described
Fig. 2 Overall adherence in pregnancy and lactation, by country and supplement. Median (N) in Ghana for pregnancy/lactation 88.1 %/85.7 %
(399), 87.0 %/85.0 % (403) and 83.7 %/80.0 % (391) for IFA, MMN and SQ-LNS, respectively. Median (N) in Malawi for pregnancy/lactation 91.7 %/
96.7 % (241), 91.0 %/97.0 % (240) and 93.8 %/96.4 % (238) for IFA, MMN and SQ-LNS, respectively
Table 2 Self-reported overall adherence in Ghana and in Malawi during pregnancy and lactation, by intervention group
Pregnancy Ghana Malawi Difference in means (95 % CIa) P-value*
Total, % (n) 81.5 (1193) 90.1 (719) −8.5 (−9.9, −7.1) <0.001
IFA, % (n) 84.5 (399) 90.5 (241) −6.0 (−7.9, −4.0) <0.001
MMN, % (n) 81.9 (403) 89.2 (240) −7.3 (−9.5, −5.0) <0.001
SQ-LNS, % (n) 78.2 (391) 90.6 (238) −12.4 (−15.3, −9.6) <0.001
Lactation Ghana Malawi Difference in means (95 % CIa) P-value*
Total, % (n) 78.5 (1193) 93.4 (719) −14.9 (−16.5, −13.3) <0.001
IFA, % (n) 80.4 (399) 93.3 (241) −12.9 (−15.4, −10.4) <0.001
MMN, % (n) 79.9 (403) 93.4 (240) −13.5 (−16.1, −10.8) <0.001
SQ-LNS, % (n) 75.0 (391) 93.5 (238) −18.5 (−21.6, −15.4) <0.001
*Pairwise comparisons of means using Wilcoxon-Mann-Whitney test
aConfidence interval obtained from t-test
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by this interviewee: Like they said, they grind the blood
tonic- the green one, the red and folic acid and mix it
with the groundnut. So if you open it and you are taking
it you’ll notice that what was grinded and mixed has
some particles left in it. So at times… you’ll feel it on your
tongue (Ghana 1706, 1st interview).
In the Malawi interviews, statements were more
positive and women typically stated that they liked
Chiponde, including its organoleptic properties. How-
ever, when probed further, some Malawian women also
said that Chiponde gave a bad aftertaste or was bitter: It
was tasty, mixing it with porridge it was really tasty …
but just to eat it like that it felt a bit bitter (Malawi
4026, 2nd interview). Some reported adding sugar to the
Chiponde to make it sweeter.
An additional feature women related to organoleptic
properties of SQ-LNS was nausea. In both countries,
several women indicated that they experienced nausea
or vomiting after they consumed SQ-LNS. Some of
the women noted that they experienced nausea and
vomiting when they mixed the SQ-LNS with some
particular foods, but if they mixed it with other foods
they did not experience any difficulties. However, it
appears that the majority of the nausea and vomiting
experienced by the women was due to their physio-
logical state in early pregnancy. When interviewed
postpartum, eating had typically become easier, as this
interviewee from Malawi who stopped eating Chi-
ponde for 2 months said: When I mixed with porridge,
I was vomiting, so I stopped, I wasn’t eating, I started
[eating] when I was 7 months [pregnant] (Malawi
3054, 2nd interview). Some mothers in Ghana also re-
ported similar behavior: When I was just pregnant
when I mixed the medicine with food and ate, some-
times I vomited. But when the pregnancy was growing,
when I took it, nothing happened to me (Ghana 1100,
2nd interview).
However, some women explained how they were un-
able to eat SQ-LNS even if they tried both during
pregnancy and postpartum as stated by one study
participant: I just prepare it for the children and when
they are stirring, I shouldn’t be near because when the
smell reaches me, I don’t feel good, just the smell. During
the second interview she still gave it to the children: Yes,
Fig. 3 Non-inferiority analysis, by country and supplement. In Ghana
mean (90 % of the mean) for adherence for IFA and MMN was 82.4 %
(74.2 %) and 80.8 % (72.7 %), respectively, and mean (95 % CI) for
adherence for SQ-LNS was 76.3 % (74.3 %, 78.3 %). In Malawi mean
(90 % of the mean) for adherence for IFA and MMN was 91.8 % (82.6 %)
and 91.2 % (82.1 %), respectively, and mean (95 % CI) for adherence for
SQ-LNS was 92.0 % (91.1 %, 92.9 %). Figure values converted to present
difference. Center of box indicates the mean and wings represent the
95 % CI
Fig. 4 Adherence time trends, by country and intervention product. Lowess curves, no weighting, bandwidth 0.6
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even now if I get a whiff of the smell I want to vomit
(Malawi 3375).
Food practices / convenience
In both countries participants described in detail how
they accommodated (or tried to accommodate) SQ-LNS
in their daily meal routines. Most of the women did this:
It is good for me, if I were to be taking it always I
wouldn’t have had any problems (Ghana 1218, 1st inter-
view). Typically women reported that they mixed SQ-
LNS with a small amount of porridge or some other
food in the morning as instructed. However, in Ghana it
was rather common for the interviewees to say that it
was difficult for them to take Nkatepa like this inter-
viewee: It is difficult for me…but I try my best to take all
(Ghana 1637, 1st interview). In Malawi, women typically
found consuming Chiponde easy as this quote illustrates:
But for me, I just cook porridge then I put in the porridge
and eat (Malawi 3365, 1st interview).
In Malawi, women described a very limited selection
of daily food alternatives besides nsima ndi ndiwo, stiff
maize porridge with sauce and porridge, phala. There
were only a few who reported spreading Chiponde on
bread or scones and a few mixing it in tea. In Ghana,
women narrated more dish options they experimented
mixing Nkatepa with (porridge, soups, bread, tea, banku,
stews). Some women in Ghana said that when the food
they liked mixing the Nkatepa with was not available,
they skipped taking it: I used it to take oats or rice water
or porridge, it is good for me, but if I am to use it to eat
soupy dishes, I am unable to eat it (Ghana 1314, 1st
interview). There were also some other non-food related
reasons reported as a cause for skipping: I went to the
hospital yesterday and I was given injection … as for that
I don’t take it [SQ-LNS] together with the injection
(Ghana 1704, 1st interview).
Later on in the trial, many participants reported that
they liked eating SQ-LNS straight from the sachet. Also
if they did not cook porridge or other suitable food, they
consumed SQ-LNS as a snack. Additionally, in Malawi,
a few women said that if there was no other food, they
would eat Chiponde from the sachet: When I can’t find
any food then I just take the Chiponde and start eating
(Malawi 8076, 1st interview). In Ghana, there were no
such accounts.
Needs perception and benefits
In Ghana, women were routinely given iron, vitamin and
mineral supplements by health personnel at the pre- and
antenatal clinics; in addition a few mentioned buying nu-
trient supplements from pharmacy shops, and some
bought herbal medications from local herbalists. In
Malawi, women mainly talked about being used to re-
ceiving “pills from the hospital” (iron and folic acid
tablets and malaria prophylaxis), and a few used medica-
tions from local healers to make birthing easier or to
prevent some illnesses of the newborn. In Ghana,
women typically referred to Nkatepa as “blood tonic
mixed with groundnut paste”. Similarly in Malawi,
women said “they explained to me that there is medicine
in Chiponde, to increase blood in the body”. Also, in
both countries, women expressed ideas about maternal
diet having an impact on the health and nutrition of
both the mother and the infant. Therefore, the expect-
ation for a supplement like SQ-LNS was that it should
replace the usual pregnancy medications, make the
mother and the infant healthy and strong, and help the
baby to develop. However, some participants said SQ-
LNS did not have any health promoting impact. Only a
few of the women expressed the need to take a supple-
ment to promote child growth; according to the women
who did not see a need to take a supplement, children
grew normally, whether the mother took supplements or
not.
In addition to SQ-LNS, some women felt they needed
to take other supplements especially if they did not eat
SQ-LNS every day like this woman in Ghana: I am not
able to take it well because it is not sweet for me, so once
in a while I mix it with Koko [porridge], so as I have not
been taking it, my blood is not much....that is why I went
to the hospital to buy this medicine, Pregnant Care
(Ghana 1637, 1st interview). Pregnant Care contains
iron, folic acid, zinc, copper, manganese, magnesium, po-
tassium; and vitamins B6, B12, C, and K.
Often women compared SQ-LNS with their earlier ex-
periences. Some considered it to be better for the health
of the mother and the infant, but some still preferred
pills and tablets. Also, when it came to side effects, some
described various symptoms with tablets, and others
with SQ-LNS. A typical way of comparing was: When I
had my first born, the way I use this medicine and the
way I used the B complex and others, I can see that this
one is good for me (Ghana 1156, 1st interview).
In both Ghana and Malawi, several women reported
positive effects on their skin: But also my body changed,
it was returning to youth on the skin, it was smooth.
(Malawi 4026, 2nd interview) When I am taking it, I
notice that there are no rashes on my body (Ghana
1218, 2nd interview).
Social environment
In Ghana, the participants reported that their husbands
and family members learned about Nkatepa either
through the study team or by the participants them-
selves informing them. None of the women whom we
interviewed reported seeking approval from their hus-
bands before enrolling in the study; they just informed
their husbands and family members about the study, like
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this woman described: I told him that this is some type
of medicine we are eating so now, if I go to the hospital
they no longer give me pills, so they said the pills they
will give us they have passed it through this one, so we
should eat it will give us strength and he said ok (Ghana
1613, 1st interview).
In Malawi, women typically thought that they should
get permission from their husbands to enroll in the
study and start taking Chiponde as this woman
expressed: He allowed me that you can join (Malawi
8255, 1st interview). Husbands’ reactions were usually
positive especially if the women discussed the issue be-
fore starting to consume Chiponde. Some husbands who
returned home after working in South Africa or bigger
towns in Malawi told their wives to drop-out of the
study. In some cases, the husbands and other relatives
also wanted to taste SQ-LNS.
In Ghana, very few of the participants reported sharing
the Nkatepa. Those who shared did so because their
family or friends wanted to find out what the Nkatepa
was like. They also did not report that they shared it
more than once. In Malawi, women frequently men-
tioned sharing. Participants reiterated that the nurses
said Chiponde was meant only for the study mothers but
there was a lot of social pressure for sharing. They talked
about hiding Chiponde sachets in the house and how
every now and then sachets went missing. Family struc-
ture in the study area in Malawi is mostly matrilineal
and sisters and their mother live close to each other.
Typically, participants reported sharing Chiponde with
their children, their sister’s children and with their sis-
ters and mothers. Selling and bartering were reported
very infrequently in both countries.
Discussion
In this study we examined the consumption of SQ-LNS
among two cohorts of pregnant and lactating women in
Ghana and Malawi. We based the analysis of adherence
on weekly/bi-weekly survey data. The mean adherence
to SQ-LNS was high (>70 %) but varied across individ-
uals from almost full adherence to almost complete
non-adherence. The mean adherence was lower in
Ghana than in Malawi and there was a decreasing trend
in acceptability over time in Ghana and an increasing
trend in Malawi. In-depth interviews provided a range of
narratives of acceptability and adherence.
The strengths of our study are the longitudinal mixed
methods approach used in data collection, the assess-
ment of both adherence and acceptability, and coding
and analysis by two independent researchers who under-
stood the local languages. Some limitations of the study
are that we did not observe participants, there was a
high level of interaction with study staff, and adherence
was self-reported, thus making social desirability bias in
reporting possible. Additionally, we cannot say that ac-
ceptability would always lead to adherence.
There is a paucity of previous literature on SQ-LNS
interventions among pregnant and lactating women. Ad-
herence has been reported in only two previous studies.
In a 2 weeks study in Ghana most of the pregnant and
lactating women reported consuming the supplements
as instructed [3]. In Bangladesh, 64 % of the pregnant
trial participants reported using SQ-LNS daily or almost
daily from the 28th weeks of gestation through the first
6 months of lactation [18, 24]. Additionally, adherence
to a similar but larger quantity LNS has been reported
to be high: in a 28 weeks study in Malawi among HIV
positive lactating women, daily adherence to supplement
(70 g/d) was 92.4 % [20] and in Burkina Faso, daily ad-
herence to supplement (72 g/d) was 75.4 % [19]. Self-
reported adherence in our trials in Ghana and in Malawi
is consistent with these previous studies.
In our trials, participants in the in-depth interviews
gave reasons for adherence to SQ-LNS. Many of them
talked of expected benefits for themselves and their in-
fants in relation to SQ-LNS. This is in line with the
health belief model focusing on an individual’s likelihood
to adopt a certain behavior that is relevant to a specific
condition or disease [30]. Another possible reason for
adherence was that some women believed that the medi-
cines they usually received during pregnancy had been
mixed into SQ-LNS. Similarly, in Guatemala the use of
ready-to-use supplementary foods (RUSF) increased pro-
portional to the product’s perception as a medicine [12].
Among Bangladeshi pregnant and lactating women, the
most common reasons for high adherence were the ben-
efits they perceived, either personally, for their infant, or
in general [18]. Participants in our trials also emphasized
that the product was recommended by health care
personnel as a reason to follow the instructions on how
to take the SQ-LNS. Despite this, sharing was a major
issue related to adherence, albeit with more women in
Malawi than in Ghana reporting sharing the SQ-LNS
with family and friends. In the Bangladesh study, 18 % of
women receiving SQ-LNS reported sharing some of the
supplements [18].
The mean self-reported overall adherence to supple-
ment consumption was lower in Ghana than in Malawi;
over time, the mean adherence increased in Malawi but
decreased in Ghana for all supplement types. A study
evaluating the factors associated with variation in com-
pliance to iron supplementation over time among Peru-
vian women reported a median adherence of 79 %
(interquartile range 65–89 %) over pregnancy [32]. In
the Peruvian study, women with low initial compliance
achieved high compliance by the end of pregnancy, simi-
lar to what was observed among Malawian women but
in contrast to Ghanaian women. This could be partly
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attributed to the fact that in our study, Ghanaian women
were more critical of the organoleptic properties of SQ-
LNS and reported that it was difficult to take or they did
not like it, whereas Malawian women were more positive
and liked the supplement. In Peru, positive health re-
ports were associated with greater compliance, and
negative reports were associated with lower compliance
[32].
In our trials, women were given a minimal set of in-
structions on how to take SQ-LNS (daily intake, not
sharing, and mixing with a small amount of food) with
consistent and reliable supply of the supplement at
home. Other studies have shown that guaranteed supple-
ment supply coupled with minimum, consistent and eas-
ily understandable information are key to effective pre-
and postnatal supplementation programmes [6, 16].
Rather little is known about acceptability of SQ-LNS
among this group of consumers: in the 2 weeks study in
Ghana, SQ-LNS were well accepted [3] and in
Bangladesh, the overall acceptability score for SQ-LNS
was high [18]. In all of these studies as well as in our
study, sensory/organoleptic (taste, mouth feel, after taste
and smell) attributes were central to acceptability. Simi-
lar issues have been reported with other types of supple-
ments. In a trial among pregnant women in Mexico,
micronutrient powders and tablets were preferred over
fortified food (Nutrivida) because participants disliked
the smell, taste and texture of the food supplement [31].
Bangladeshi women suggested that specific preparation
techniques (taking supplements with or without certain
foods) could make consumption of SQ-LNS easier but
the smell could still be a challenge [18].
In our trials, acceptability differed by country and
there might be several reasons for this: there were more
women in Malawi that perceived their households as
food insecure than in Ghana, and staple foods were dif-
ferent with more variation in Ghana [4, 9]. It is therefore
plausible that women in Ghana were more critical about
the felt qualities of supplements, and Malawian women
more willingly consume supplements given to them.
In our trials, some participants experienced nausea
after consuming SQ-LNS whilst pregnant but nausea
symptoms subsided in late pregnancy. Very few partici-
pants reported SQ-LNS-related nausea or vomiting dur-
ing lactation. Among Bangladeshi pregnant and lactating
women receiving SQ-LNS, low-adherers reported the
‘bad smell of the supplement’, and ‘feeling nausea and
vomiting’ as some of the reasons for their consumption
patterns [18]. Similar results have been reported with for
example iron supplementation: pregnant women may be
reluctant to take iron supplements because of the
gastrointestinal discomfort [15, 23].
A few participants reported sharing SQ-LNS in Ghana
to satisfy the curiosity of family and friends who wanted
to find about the contents of the SQ-LNS sachets. Shar-
ing was more frequent in Malawi, and can be attributed
to social pressure and matrilineal family structure. How-
ever, because according to the in-depth interviews the
children received only a small portion of mother’s sup-
plement, it is not likely to be harmful to them.
Conclusions
Self-reported sustained adherence to consume SQ-LNS
daily was high in both sites but lower in Ghana than in
Malawi. In Ghana adherence decreased over time
whereas in Malawi adherence increased. Acceptability
and adherence appeared interlinked, complex and con-
text related. Achieving sustained consumption of SQ-
LNS may require tailoring user instructions, health pro-
motion messages and possibly the supplementary prod-
ucts by preferences of the intended consumers.
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